Non-alcoholic fatty liver disease (NAFLD) is an independent predictor of both type 2 diabetes and carotid atherosclerosis, according to two studies…. 

Women with diabetes were 14% less likely than those without the disease to undergo breast cancer screening…. 

The American Heart Association questions the findings of a new analysis suggesting that most people around the world are consuming just the right amount of sodium…. 

Circulating levels of vitamin D had no apparent influence on overall risk for cardiovascular disease in older men…. 

The Food and Drug Administration (FDA) has approved albiglutide (Tanzeum, GlaxoSmithKline), a once-weekly injectable glucagonlike peptide 1 (GLP-1) receptor agonist to treat type 2 diabetes…. “Tanzeum is a new treatment option for the millions of Americans living with type 2 diabetes,” Curtis Rosebraugh, MD, MPH, director of the Office of …

A new study by a University of Miami (UM) researcher analyzed nearly three decades of data on the effect of chromium supplementation on blood sugars….

The effects of ACEIs and ARBs on multiple outcomes in type 2 diabetes patients…. 

A recent analysis of youth with type 1 or type 2 diabetes shows that the incidence of DKA continues to be high…. 

Inter-arm systolic blood pressure differences may be a sign of bad things to come….

Noninvasive methods for screening pediatric patients with type 1 diabetes for peripheral diabetic neuropathy (DN) have low sensitivity, according to a systematic review….